Willow Biosciences Inc T.WLLW

Alternate Symbol(s): CANSF

Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.

TSX:WLLW - Post by User

Willow Biosciences Inc

Bullboard Posts

Comment by Oxyuridon Jan 29, 2003 2:41pm

117 Views

Post# 5815498

RE: TSX ???

Flavoie Yep, I think your bang-on there. I believe management is trying to make their case to the TSX to continue listing. However, you really have to wonder how hard this management will try to keep it listed. We shall see. Also, not to get into a p!ssing match with Whitesbull but MGX has been under expedited review by the TSX since Dec 16th. However, lots of other companies get delisted or suspended shortly after one of those announcements. Cheers, Oxyurid

Bullboard Posts

Mullen Group's Robust Case for Value, Part 1: Less-than-Truckload